Healthcare Swiss Investing Ideas

CHF 314.7
11.2% undervalued intrinsic discount
Revenue
4.11% p.a.
Profit Margin
24.68%
Future PE
21.33x
Price in 2029
CHF 342.85
CHF 180.07
14.6% undervalued intrinsic discount
Revenue
12.6% p.a.
Profit Margin
14.22%
Future PE
30.82x
Price in 2029
CHF 198.57
CHF 58
17.6% undervalued intrinsic discount
Revenue
1.69% p.a.
Profit Margin
7.73%
Future PE
20.56x
Price in 2029
CHF 67.1
CHF 5.6
1.3% undervalued intrinsic discount
Revenue
2% p.a.
Profit Margin
5.48%
Future PE
9.96x
Price in 2029
CHF 6.27